TPD & Induced Proximity Summit Leaderboard
  • Monday, July 27, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 689

Author

Pharma Journalist 8962 posts 0 comments

CBT and Zhejiang Bossan Enter into a Collaboration and License Agreement to Develop Combination…

Nov 27, 2018
CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) announced that they have entered into a clinical collaboration and license agreement to develop their…
Read More...

Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer…

Nov 27, 2018
Edge Therapeutics and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement. The merger is expected to create a…
Read More...

Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA

Nov 27, 2018
Telix Pharmaceuticals Limited has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares. The acquisition of ANMI…
Read More...

Fusion Antibodies and Analytics Engines to Incorporate Artificial Intelligence into Its World Class…

Nov 27, 2018
Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine…
Read More...

Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218

Nov 27, 2018
Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the…
Read More...

Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment

Nov 27, 2018
Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently reported impressive preclinical results. The…
Read More...

FDA grants Fasenra Orphan Drug Designation for Eosinophilic Granulomatosis with Polyangiitis

Nov 27, 2018
AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic…
Read More...

European Commission approves Mundipharma’s Pelmeg to treat febrile neutropenia

Nov 26, 2018
The Mundipharma network of independent associated companies announced that the European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for…
Read More...

SMi’s Drug Discovery Chemistry announces key industry speakers and agenda released

Nov 23, 2018
SMi’s Pharma is proud to announce the 3rd Annual Drug Discovery Chemistry Conference is back and the conference is taking place at the Copthorne Tara Hotel in London, UK on 18th and…
Read More...

Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis

Nov 23, 2018
Shanghai Roche Pharmaceuticals and Ascletis BioScience jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis. Following…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Bora to Manufacture GERD Drug for U.S. Phase 3 Trial
  • FDA Grants Fast Track Status to Lundbeck’s Narcolepsy Drug
  • Affinia Gene Therapy Wins FDA Orphan Drug Status for Rare Heart Disease
  • BeOne Invests $300 Million in U.S. Manufacturing Expansion
  • Kairos and Bayer Partner on Advanced Prostate Cancer Study

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.